Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamsulosin for Post-Operative Urinary Retention in Thoracic Surgery
NCT06262048Phase 2Recruiting
- Start
- Oct 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tamsulosin in postoperative urinary retention (POUR) (2 arms). Primary endpoints: Enrollment Effectiveness at 4 months, Monthly recruitment at 4 months and 1 more. Started Oct 2024; status: recruiting.
02
Drugs
tamsulosin
03
Conditions
postoperative urinary retention (POUR)
Beyond the preview
Go deeper on NCT06262048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06262048.